Peripheral sequestration of abeta on transport systems

运输系统中 abeta 的外围隔离

基本信息

  • 批准号:
    7023295
  • 负责人:
  • 金额:
    $ 18.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-02-15 至 2006-10-01
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The idea of interdependence between peripheral and CNS levels of A/3 in the pathogenesis of Alzheimer's disease is fairly new. The observation that immunotherapy with anti-A/3 antibodies led to a significant increase in peripheral A/3 formed the basis of the peripheral sink hypothesis set forth by Dave Holtzman. Subsequent observations of a peripheral effect on A/3 was shown by our own lab, both for antibody-mediated sequestration and using other peripheral A/3 binding agents (PABBAs) such as gelsolin that does not cross into the brain. Virtually nothing has been published showing the mechanism by which peripheral sequestration works under any experimental paradigm. A/3 can be transferred between the brain and periphery either by passive bulk flow, or by active transport. This proposal aims to examine which of these two systems is impacted by gelsolin-mediated peripheral sequestration, and the dynamic flux of A/3 in specific brain compartments, in the presence, or absence of aggregated amyloid. This work will extend our published observations providing mechanistic evidence that this novel therapeutic approach is worthy of further development, and by identifying which systems are affected, it will direct efforts to new targets that could be developed for clinical use.
描述(申请人提供):在阿尔茨海默病的发病机制中,外周和中枢神经系统A/3水平之间的相互依赖的想法是相当新的。抗A/3抗体免疫治疗导致外周A/3显著增加的观察结果构成了Dave Holtzman提出的外周下沉假说的基础。我们自己的实验室随后观察到了A/3的外周效应,包括抗体介导的隔离和使用其他外周A/3结合剂(PABBA),如不进入大脑的明胶。几乎没有发表过任何关于外周隔离在任何实验范式下起作用的机制的文章。A/3可以通过被动大量流动或主动运输在大脑和外周之间转移。这项建议旨在研究这两个系统中的哪个系统受到明胶蛋白介导的外周隔离的影响,以及在存在或不存在聚集淀粉样蛋白的情况下,特定脑区A/3的动态流量。这项工作将扩展我们发表的观察结果,提供机制证据,证明这种新的治疗方法值得进一步开发,并通过确定哪些系统受到影响,将努力指向可以开发用于临床的新靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karen Duff其他文献

Karen Duff的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karen Duff', 18)}}的其他基金

Differential vulnerability to tauopathy in Alzheimer's disease and Frontotemporal Lobe Dementia
阿尔茨海默病和额颞叶痴呆患者对 tau 蛋白病的易感性存在差异
  • 批准号:
    9765938
  • 财政年份:
    2019
  • 资助金额:
    $ 18.75万
  • 项目类别:
Differential vulnerability to tauopathy in Alzheimer's disease and Frontotemporal Lobe Dementia
阿尔茨海默病和额颞叶痴呆患者对 tau 蛋白病的易感性存在差异
  • 批准号:
    10281586
  • 财政年份:
    2019
  • 资助金额:
    $ 18.75万
  • 项目类别:
Entorhinal-hippocampal circuit dysfunction in AD mice
AD小鼠内嗅海马回路功能障碍
  • 批准号:
    9118863
  • 财政年份:
    2015
  • 资助金额:
    $ 18.75万
  • 项目类别:
Metabolite profiling to identify AD-relevant pathways affected by apoe variants
代谢物分析可识别受 apoe 变异影响的 AD 相关途径
  • 批准号:
    8770662
  • 财政年份:
    2014
  • 资助金额:
    $ 18.75万
  • 项目类别:
Propagation of tauopathy: role of degeneration and impact of immunotherapy
tau 蛋白病的传播:变性的作用和免疫治疗的影响
  • 批准号:
    8534504
  • 财政年份:
    2013
  • 资助金额:
    $ 18.75万
  • 项目类别:
Propagation of tauopathy: role of degeneration and impact of immunotherapy
tau 蛋白病的传播:变性的作用和免疫治疗的影响
  • 批准号:
    8842723
  • 财政年份:
    2013
  • 资助金额:
    $ 18.75万
  • 项目类别:
Propagation of tauopathy: role of degeneration and impact of immunotherapy
tau 蛋白病的传播:变性的作用和免疫治疗的影响
  • 批准号:
    8705062
  • 财政年份:
    2013
  • 资助金额:
    $ 18.75万
  • 项目类别:
Spatio temporal relationship of pathology and functional decline with tauopathy
tau 蛋白病病理和功能衰退的时空关系
  • 批准号:
    8473344
  • 财政年份:
    2012
  • 资助金额:
    $ 18.75万
  • 项目类别:
Autophagic Clearance of Aberrant Tau: Biochemical and Therapeutic Implications
异常 Tau 蛋白的自噬清除:生化和治疗意义
  • 批准号:
    8204248
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
Spatio temporal relationship of pathology and functional decline with tauopathy
tau 蛋白病病理和功能衰退的时空关系
  • 批准号:
    8133243
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:

相似海外基金

Solid State NMR Studies of Amyloid Proteins
淀粉样蛋白的固态核磁共振研究
  • 批准号:
    10446323
  • 财政年份:
    2017
  • 资助金额:
    $ 18.75万
  • 项目类别:
Solid State NMR Studies of Amyloid Proteins
淀粉样蛋白的固态核磁共振研究
  • 批准号:
    10687158
  • 财政年份:
    2017
  • 资助金额:
    $ 18.75万
  • 项目类别:
Solid State NMR Studies of Amyloid Proteins
淀粉样蛋白的固态核磁共振研究
  • 批准号:
    9366854
  • 财政年份:
    2017
  • 资助金额:
    $ 18.75万
  • 项目类别:
Development of aggregation inhibition strategy for pathogenic amyloid proteins
致病性淀粉样蛋白聚集抑制策略的开发
  • 批准号:
    16H06216
  • 财政年份:
    2016
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Young Scientists (A)
Elucidation of the mechanisms on aggregation and toxicity of plant amyloid proteins which are toxic in the presence of metals
阐明在金属存在下有毒的植物淀粉样蛋白的聚集和毒性机制
  • 批准号:
    23380192
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Demonstration of the abnormal conformational transition of amyloid proteins and it's application as an early diagnostic tool
淀粉样蛋白异常构象转变的演示及其作为早期诊断工具的应用
  • 批准号:
    21200072
  • 财政年份:
    2009
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)
Metabolism of amyloid proteins and methods for detecting amyloid proteins
淀粉样蛋白的代谢和检测淀粉样蛋白的方法
  • 批准号:
    21790541
  • 财政年份:
    2009
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of aggregation disrupters for amyloid proteins
淀粉样蛋白聚集破坏剂的开发
  • 批准号:
    17310132
  • 财政年份:
    2005
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Inhibition of axonal transport of hippocampal neurons by amyloid proteins: relation to Alzheimer's disease
淀粉样蛋白抑制海马神经元轴突运输:与阿尔茨海默病的关系
  • 批准号:
    11670638
  • 财政年份:
    1999
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
RAB GTPASES AND TRAFFICKING OF BETA AMYLOID PROTEINS
RAB GTP 酶和 β 淀粉样蛋白的贩运
  • 批准号:
    6149928
  • 财政年份:
    1998
  • 资助金额:
    $ 18.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了